UBS AM’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-24,598
Closed -$846K 2681
2014
Q4
$846K Buy
24,598
+900
+4% +$29.4K ﹤0.01% 1662
2014
Q3
$707K Hold
23,698
﹤0.01% 1696
2014
Q2
$475K Buy
23,698
+600
+3% +$13.8K ﹤0.01% 1929
2014
Q1
$628K Buy
23,098
+5,200
+29% +$138K ﹤0.01% 1748
2013
Q4
$371K Sell
17,898
-2,100
-11% -$39.6K ﹤0.01% 1987
2013
Q3
$365K Hold
19,998
﹤0.01% 1962
2013
Q2
$333K Buy
+19,998
New +$319K ﹤0.01% 1932

Other funds holding AUXL

UBS AM's AUXL Position: Q1 2015 in Review

UBS AM sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 24,598 shares — an estimated $846K sold.

UBS AM first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $846K in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • UBS AM reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • UBS AM sold 24,598 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $846K.
  • UBS AM first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • UBS AM's AUXILIUM PHARAMCEUTICALS INC position peaked at $846K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.